Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
avapritinib
blueprint medicines
boston
boston blog main
life sciences
national blog main
biotech
boston top stories
cancer
clinical trials
eli lilly
genentech
medullary thyroid cancer
national top stories
non-small cell lung cancer
pralsetinib
roche
san francisco blog main
san francisco top stories
selpercatinib
thyroid cancer
andrew berens
cancer drugs
capmatinib
cstone pharmaceuticals
deals
deciphera pharmaceuticals
europe blog main
europe top stories
european medicines agency
fda
fisogatinib
flatiron health
gastrointestinal stromal tumor
gastrointestinal stromal tumors
gist
gleevec
hepatocellular carcinoma
imatinib
indiana blog main
What
approval
blueprint
3
×
cancer
drug
3
×
fda
3
×
medicines
ret
address
announced
approves
candidate
carries
certain
chasing
currently
deadly
deciphera
designed
filing
forms
genetic
gi
latest
marketing
medicine
morning
muscle
pact
pass
pharamceuticals
plans
regulatory
review
roche
seek
signature
signatures
targeted
targeting
team
Language
unset
Current search:
drug
×
blueprint
×
fda
×
@xconomy.com
3 years ago
FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures
@xconomy.com
3 years ago
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact
@xconomy.com
4 years ago
Chasing Blueprint, Deciphera Plans FDA Filing for GI Cancer Drug